• Biomedical Bonding

BMB is moving to new premises!

Updated: Sep 30

BMB secures new R&D facilities at Greenhouse labs, GHL.

The new address is located at KTH Royal Institute of Technology main campus in Stockholm, Sweden.

Our CEO, Prof. Michael Malkoch, further explains: This move is logical and will provide BMB with the necessary infrastructure available at KTH to further develop our Bonevolent® products